Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Pd-1/Pd-L1 Blockade Therapy With Atezolizumab: A New Paradigm in the Treatment of Non-Small Cell Lung Cancer (Nsclc)
Elham Mirzaean
Elham Mirzaean

Assistant Professor of Pathology

Department Pathology

School of Medicine

Shariati Hospital

Tehran University of Medical Sciences

All Documents